Women who follow the Mediterranean diet have a lower risk of stroke, especially ischemic and hemorrhagic types, according to ...

Overall, women who stuck most closely to an eating pattern resembling the Mediterranean diet had an 18% lower risk of any ...

Bayer is vying to be first to market in the oral Factor XIa category against Bristol Myers Squibb and Johnson & Johnson, ...

Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and ...

The rationale behind the treatment is that because genetic FXI deficiency has been linked with reduced risk of ischemic ...

Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...

Asundexian cut the risk of an additional stroke by 26% in a large Phase 3 trial without accompanying safety issues, boosting the commercial outlook for an emerging class of anti-clotting drugs.

Overlooked or underestimated risk factors may warrant more consideration in stroke prevention and epidemiology, according to ...

Rehabilitation from stroke has traditionally focused on improving the function of the most severely affected arm. But ...